1.Four cases of meconium peritonitis in infants.
Ji-yan ZHENG ; Xiao-lu MA ; Li-ping SHI
Chinese Journal of Pediatrics 2004;42(12):952-953
Humans
;
Infant, Newborn
;
Meconium
;
Peritonitis
;
etiology
3.Non-O group 1 Vibrio cholerae Septicemia and Peritonitis: Report of Two Cases.
Yunsop CHONG ; Oh Hun KWON ; Samuel Y LEE ; Byung Soo KIM ; Jin Sik MIN
Yonsei Medical Journal 1985;26(1):82-84
Two strains of non-O group 1 Vibrio cholerae (non-0:1V. cholerae) were isolated from blood of a woman who had undergone a gastrectomy and from peritoneal fluid of a man with an impaired liver function. Microbiology laboratories in countries where raw fish and shellfish are frequently consumed should consider the possibility of non-0:1 V. cholerae when they identify vibrios from extraintestinal sources.
Adult
;
Cholera/complications*
;
Female
;
Human
;
Male
;
Middle Age
;
Peritonitis/etiology*
;
Septicemia/etiology*
;
Vibrio cholerae/isolation & purification
4.Spontaneous bacterial peritonitis.
Chinese Journal of Hepatology 2003;11(7):439-440
5.Clinical characteristics and treatment outcomes of first peritonitis in patients receiving long-term peritoneal dialysis: a multicenter study.
Jing ZHAO ; Liming YANG ; Xueyan ZHU ; Xiaoxuan ZHANG ; Xinyang LI ; Shichen LIU ; Xiaohua ZHUANG ; Wenhua ZHOU ; Ping LUO ; Wenpeng CUI
Journal of Southern Medical University 2020;40(12):1740-1746
OBJECTIVE:
To analyze the clinical characteristics and treatment outcomes of the first episode of peritoneal dialysis-associated peritonitis (PDAP) in patients receiving long-term peritoneal dialysis.
METHODS:
The clinical data of patients with the first episode of PDAP in 4 general hospitals in Jilin Province from 2013 to 2019 were collected retrospectively. According to the duration of dialysis, the patients were divided into long-term (≥36 months) and short-term (< 36 months) dialysis groups for comparison of the clinical data, treatment outcomes and long-term prognostic events.
RESULTS:
A total of 625 patients with PDAP were enrolled, including 93 on long-term and 532 on short-term dialysis. Compared with those on short-term dialysis, the patients on long-term dialysis had significantly higher hemoglobin levels and lower glomerular filtration rates when the first episode of PDAP occurred (
CONCLUSIONS
Compared with those on short-term dialysis, patients on long-term dialysis are prone to gram-negative bacterial infection when the first episode of PDAP occurs with worse treatment outcomes but similar long-term outcomes. Long-term dialysis is an independent risk factor of extubation and treatment failure for the first episode of PDAP, and fungal and mixed bacterial infections are independent risk factors for treatment failure of the first PDAP in patients with long-term dialysis.
Humans
;
Kidney Failure, Chronic/therapy*
;
Peritoneal Dialysis/adverse effects*
;
Peritonitis/etiology*
;
Retrospective Studies
;
Treatment Outcome
6.Clinical Characteristics and Treatment Outcome of Pseudomonas Peritoneal Dialysis-associated Peritonitis.
Ce NI ; Li-Ming YANG ; Xue-Yan ZHU ; Xiao-Xuan ZHANG ; Wen-Hua ZHOU ; Shun-Yun XIE ; Meng-Yuan YU ; Xiao-Hua ZHUANG ; Ping LUO ; Wen-Peng CUI
Acta Academiae Medicinae Sinicae 2022;44(1):45-52
Objective To explore the clinical characteristics and treatment of Pseudomonas peritoneal dialysis-associated peritonitis(PsP). Methods The data of patients receiving peritoneal dialysis in four tertiary hospitals in Jilin province from 2015 to 2019 were retrospectively analyzed.According to the etiological classification,the patients with peritoneal dialysis-associated peritonitis(PDAP)were classified into PsP group and non-PsP group.The incidence of PsP was calculated,and the clinical characteristics and treatment outcomes of the two groups were compared.Kaplan-Meier method was used to draw the survival curve,and Cox regression was performed to analyze the risk factors affecting the technical failure of PsP.The treatment options of Pseudomonas aeruginosa-caused PDAP and the drug sensitivity of PsP were summarized. Results A total of 1530 peritoneal dialysis patients with complete data were included in this study,among which 439 patients had 664 times of PDAP.The incidence of PsP was 0.007 episodes/patient-year.PsP group had higher proportion of refractory peritonitis(41.38% vs.19.69%,P=0.005),lower cure rate(55.17% vs.80.79%, P=0.001),and higher extubation rate(24.14% vs.7.09%,P=0.003)than non-PsP group.The technical survival rate of PsP group was lower than that of non-PsP group(P<0.001).Multivariate Cox regression analysis showed that Pseudomonas aeruginosa was an independent risk factor for technical failure in patients with PsP(HR=9.020,95%CI=1.141-71.279,P=0.037).Pseudomonas was highly sensitive to amikacin,meropenem,and piperacillin-tazobactam while highly resistant to compound sulfamethoxazole,cefazolin,and ampicillin. Conclusion The treatment outcome of PsP is worse than that of non-PsP,and Pseudomonas aeruginosa is an independent risk factor for technical failure of PsP.
Humans
;
Peritoneal Dialysis/adverse effects*
;
Peritonitis/etiology*
;
Pseudomonas
;
Retrospective Studies
;
Treatment Outcome
7.Sclerosing Encapsulating Peritonitis (Abdominal Cocoon) after Abdominal Hysterectomy.
Won Na SUH ; Sang Kil LEE ; Hyun CHANG ; Hye Jin HWANG ; Woo Jin HYUNG ; Young Nyun PARK ; Tae Il KIM
The Korean Journal of Internal Medicine 2007;22(2):125-129
Sclerosing encapsulating peritonitis (SEP) is a poorly understood and rarely documented cause of small bowel obstruction. Although recurrent peritonitis has been reported as the main contributory factor leading to secondary SEP, the pathogenesis of primary (idiopathic) SEP is still uncertain. A 40-year-old woman with a history of total abdominal hysterectomy due to gestational trophoblastic disease presented with progressive lower abdominal pain and abdominal distension. Ultrasonography and contrast-enhanced abdomen-pelvis computed tomography of the abdomen revealed encapsulation of the entire small bowel with a sclerotic capsule. At laparotomy, a fibrous thick capsule encasing small bowel loops was revealed. Extensive adhesiolysis and removal of the capsule from the bowel loops were performed. The patient recovered uneventfully; she was discharged without complications. SEP is a rare cause of small bowel obstruction. We treated a case of abdominal cocoon with intestinal partial obstruction in a woman with a history of abdominal hysterectomy due to gestational trophoblastic disease. Surgical treatment was effective and the patient recovered without complication.
Adult
;
Female
;
Humans
;
Hysterectomy/*adverse effects
;
Intestinal Obstruction/diagnosis/*etiology
;
Intestine, Small/*pathology
;
Peritonitis/diagnosis/*etiology/surgery
;
Sclerosis/*pathology
9.Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic Resistance.
Joon Young SONG ; Moon H NAHM ; M Allen MOSELEY
Journal of Korean Medical Science 2013;28(1):4-15
Streptococcus pneumoniae can asymptomatically colonize the nasopharynx and cause a diverse range of illnesses. This clinical spectrum from colonization to invasive pneumococcal disease (IPD) appears to depend on the pneumococcal capsular serotype rather than the genetic background. According to a literature review, serotypes 1, 4, 5, 7F, 8, 12F, 14, 18C, and 19A are more likely to cause IPD. Although serotypes 1 and 19A are the predominant causes of invasive pneumococcal pneumonia, serotype 14 remains one of the most common etiologic agents of non-bacteremic pneumonia in adults, even after 7-valent pneumococcal conjugate vaccine (PCV7) introduction. Serotypes 1, 3, and 19A pneumococci are likely to cause empyema and hemolytic uremic syndrome. Serotype 1 pneumococcal meningitis is prevalent in the African meningitis belt, with a high fatality rate. In contrast to the capsule type, genotype is more closely associated with antibiotic resistance. CC320/271 strains expressing serotype 19A are multidrug-resistant (MDR) and prevalent worldwide in the era of PCV7. Several clones of MDR serotype 6C pneumococci emerged, and a MDR 6D clone (ST282) has been identified in Korea. Since the pneumococcal epidemiology of capsule types varies geographically and temporally, a nationwide serosurveillance system is vital to establishing appropriate vaccination strategies for each country.
Drug Resistance, Multiple, Bacterial
;
Empyema/etiology
;
Hemolytic-Uremic Syndrome/etiology
;
Humans
;
Meningitis/etiology
;
Peritonitis/etiology
;
Pneumococcal Infections/complications/*immunology
;
Pneumonia, Pneumococcal/immunology
;
Serotyping
;
Streptococcus pneumoniae/*classification/pathogenicity
10.Current status of liver diseases in Korea: Liver cirrhosis.
The Korean Journal of Hepatology 2009;15(Suppl 6):S40-S49
Liver cirrhosis represents the final common pathway of virtually all chronic liver diseases, and is characterized by an accumulation of extracellular matrix rich in fibrillar collagens. Patients with cirrhosis are at risk of developing many potential complications. The most common complication seen in patients with liver cirrhosis is ascites, and the most lethal one is bleeding varices. Other intermediate and late stage complications include spontaneous bacterial peritonitis, hepatic encephalopathy, and hepatorenal syndrome. The mortality and morbidity attributable to liver disease in Korea have decreased continuously over the past decades, probably due to the implementation of universal vaccination and potent antiviral therapies. In addition, recent advances in the understanding of the pathophysiology of cirrhosis and in various management approaches to cirrhosis complications will contribute to the steady improvement in patient outcomes in this country. This review article outlines recent changes in etiologies and prognosis, and the advances in management of cirrhosis in Korea.
Ascites/etiology
;
Esophageal and Gastric Varices/etiology
;
Gastrointestinal Hemorrhage/etiology
;
Hepatic Encephalopathy/etiology
;
Hepatorenal Syndrome/etiology
;
Humans
;
Hypertension, Portal/etiology
;
Korea/epidemiology
;
*Liver Cirrhosis/complications/epidemiology/therapy
;
Peritonitis/etiology
;
Prognosis
;
Risk Factors